Search

Your search keyword '"Gural, Alexander"' showing total 181 results

Search Constraints

Start Over You searched for: Author "Gural, Alexander" Remove constraint Author: "Gural, Alexander"
181 results on '"Gural, Alexander"'

Search Results

3. Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial

12. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma

17. case series of eosinophilic myocarditis: different faces of the same coin.

20. Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice

25. Venetoclax is safe and efficacious in relapsed/refractory AML

26. Venetoclax Is Safe and Efficacious in Relapsed/ Refractory AML

29. Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia

31. A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

35. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity

39. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series

40. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia

42. Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients

43. Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

45. The Acetylation of AML1-ETO Is Required for Leukemogenesis.

46. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity

50. A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Catalog

Books, media, physical & digital resources